CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Fertissimo aims to enhance in vitro fertilization (IVF) success rates by using a novel biomarker to identify viable embryos more accurately. This non-invasive method assesses oxidative stress in embryo culture media, allowing for improved single embryo transfers and reducing the need for multiple transfers.
Low rates of pregnancy in IVF procedure is due to being unable to identify viable embryos for transfer.
As a result, multiple embryo transfer (MET) is practiced to increase the chances of pregnancy.
This is a costly procedure with riskier outcomes, which on average only equates to a 1 out of 4 rate of pregnancy success.
In order to minimise the cost and risk outcomes with MET, there are increasing trends have been adopted to accommodate single embryo transfer (SET). SET however, requires more ef…
CARMEL DIAGNOSTICS LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Israel, CAESAEA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
